메뉴 건너뛰기




Volumn 102, Issue 31, 2005, Pages 11011-11016

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

Author keywords

Drug resistance; Gatekeeper mutation; Kinase inhibitor

Indexed keywords

4 [6 METHOXY 7 [3 (1 PIPERIDINYL)PROPOXY] 4 QUINAZOLINYL] 1 PIPERAZINECARBOXYLIC ACID (4 ISOPROPOXYPHENYL)AMIDE; ABELSON KINASE; BCR ABL PROTEIN; CANERTINIB; CYCLOPROPANECARBOXYLIC ACID [4 [4 (4 METHYL 1 PIPERAZINYL) 6 (5 METHYL 2H PYRAZOL 3 YLAMINO) 2 PYRIMIDINYLTHIO]PHENYL]AMIDE; DASATINIB; DORAMAPIMOD; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; IMATINIB; LAPATINIB; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MUTANT PROTEIN; PELITINIB; PROTEIN KINASE INHIBITOR; STEM CELL FACTOR; SUNITINIB; THREONINE; UNCLASSIFIED DRUG; VANDETANIB;

EID: 23344440655     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0504952102     Document Type: Article
Times cited : (508)

References (52)
  • 1
    • 9244222261 scopus 로고    scopus 로고
    • Sawyers, C. (2004) Nature 432, 294-297.
    • (2004) Nature , vol.432 , pp. 294-297
    • Sawyers, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.